Are you up to date on the latest information on frontline induction, consolidation, and maintenance regimens for patients with newly diagnosed myeloma?
New approaches promise to transform care in multiple myeloma again. Read my thoughts on the most promising novel agents in clinical trial!
Gain practical insights for your care of patients with relapsed/refractory myeloma
Suzanne Lentzsch, MD, PhD, talks about her experiences with COVID-19 as she cares for patients with myeloma.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.